WesternBreeze™ 化学发光试剂盒,抗小鼠
Product Image
Invitrogen™

WesternBreeze™ 化学发光试剂盒,抗小鼠

WesternBreeze® 化学发光试剂盒可在进行 western 转印或直接与溶液结合(斑点印迹)后检测膜(硝酸纤维素或 PVDF)上固定的蛋白。使用即用型碱性磷酸酶了解更多信息
Have Questions?
货号数量
WB71041 kit
货号 WB7104
价格(CNY)
8,250.00
1 kit
添加至购物车
数量:
1 kit
价格(CNY)
8,250.00
1 kit
添加至购物车
WesternBreeze® 化学发光试剂盒可在进行 western 转印或直接与溶液结合(斑点印迹)后检测膜(硝酸纤维素或 PVDF)上固定的蛋白。使用即用型碱性磷酸酶 CDP-Star® 化学发光底物进行检测。可通过 X 射线膜或 CDP-Star® 兼容成像系统捕获蛋白条带。WesternBreeze® 化学发光试剂盒提供:

•高特异性、干净背景
•超灵敏度 - 可检测飞克水平
•持续时间长达 5 天的信号
•在 3 小时内提供结果
•永久摄影图像
仅供科研使用。不可用于诊断程序。
规格
交叉反应性小鼠
数量1 kit
反应性小鼠
运输条件湿冰
底物类型AP(碱性磷酸酶)底物
检测方法化学发光
膜兼容性硝酸纤维素、PVDF
产品线WesternBreeze
产品类型Western 印迹试剂盒
Unit Size1 kit
内容与储存
WesternBreeze™ 化学发光试剂盒包括封闭溶液、一抗稀释液、即用型二抗溶液(抗小鼠、抗兔或抗山羊)、即用型化学发光底物、洗涤液和孵育盘、预切割滤纸、用于膜上形成均匀的底物显影的聚酯片。每个试剂盒含有用于 20 次印迹的全套试剂。试剂盒储存于 +4°C 下。妥善储存时,可保证稳定储存 6 个月。

常见问题解答 (FAQ)

WesternBreeze化学发光检测试剂盒中的二抗溶液是否可以作为独立产品购买?

AP连接的山羊抗鼠和山羊抗兔二抗溶液可作为独立产品(货号WP20006和WP20007)购买,但是,AP连接的兔抗山羊二抗溶液不可作为独立产品购买。

WesternBreeze化学发光检测试剂盒中的封闭液/稀释液和抗体洗涤液是否可以作为独立产品购买?

可以,您可使用以下货号单独购买这些产品:

•货号WB7001(封闭液/稀释液A)
•货号WB7002(封闭液/稀释液B)
•货号WB7050(封闭液/稀释液A & B组合装)
•货号WB7003(抗体洗涤液)

WesternBreeze化学发光检测试剂盒中的化学发光底物和化学发光底物增强剂是否可以作为独立产品购买?

可以,您可使用以下货号单独购买这些产品:

•化学发光底物,货号WP20002
•化学发光底物增强剂,货号WP20003

我应该如何制备用于WesternBreeze化学发光检测的膜?

对于蛋白质免疫印迹,将蛋白质从SDS-PAGE凝胶转印到硝化纤维素或PVDF膜上后,立即使用20 mL纯水洗膜2次,每次5分钟,从而除去部分凝胶和转移缓冲液成分以及弱结合蛋白质。随后,膜可立即用于WesternBreeze化学发光免疫检测实验。
或者,将洗过的膜放在一张干净的滤纸上,在微热气流或红外灯下蒸干。适当干燥的膜可在4℃的密封容器内保存7天,保存时间取决于抗原。经水洗和干燥的硝化纤维素膜可立即用于WesternBreeze化学发光免疫检测实验方案。但是,经水洗和干燥的PVDF膜需要在甲醇中再润湿,随后用20 mL水洗涤2次,每次5分钟,最后用于WesternBreeze化学发光免疫检测实验。
对于非变性PAGE蛋白质免疫印迹,建议在所有洗涤步骤前实施干燥步骤,改善蛋白质与膜的结合。干燥后,应使用20 mL水将硝化纤维素膜洗涤2次,每次5分钟,然后再用于WesternBreeze化学发光免疫检测实验方案。干燥的PVDF膜需要在甲醇中再润湿,随后用20 mL水洗涤2次,每次5分钟,最后用于WesternBreeze化学发光免疫检测实验。

Why is the actual band size on a western blot different from the predicted size of the protein?

Western blotting is based on the separation of proteins by their size on a gel. However, migration of proteins through the gel matrix is also affected by other factors, which may cause the observed band size to be different from the predicted size.

Common causes are:
-Post-translational modification; for example phosphorylation and glycosylation increase the size of the protein
-Post-translation cleavage; many proteins are synthesized as precursor proteins, and then cleaved to give the active form
-Multimers, for example dimerization of a protein. This is usually prevented under reducing conditions, although strong interactions can result in the appearance of higher bands
-Splice variants; alternative splicing may result in different sized proteins being produced from the same gene
-Relative charge; the composition of amino acids (charged vs. non-charged)

Find additional tips, troubleshooting help, and resources within our Protein Electrophoresis and Western Blotting Support Center.

引用和文献 (5)

引用和文献
Abstract
Dexras1/AGS-1 inhibits signal transduction from the Gi-coupled formyl peptide receptor to Erk-1/2 MAP kinases.
Authors: Graham Timothy E; Prossnitz Eric R; Dorin Richard I;
Journal:J Biol Chem
PubMed ID:11751935
'Dexras1 is a novel GTP-binding protein (G protein) that was recently discovered on the basis of rapid mRNA up-regulation by glucocorticoids in murine AtT-20 corticotroph cells and in several primary tissues. The human homologue of Dexras1, termed activator of G protein signaling-1 (AGS-1), has been reported to stimulate signaling by ... More
In Saccharomyces cerevisiae, the inositol polyphosphate kinase activity of Kcs1p is required for resistance to salt stress, cell wall integrity, and vacuolar morphogenesis.
Authors: Dubois Evelyne; Scherens Bart; Vierendeels Fabienne; Ho Melisa M W; Messenguy Francine; Shears Stephen B;
Journal:J Biol Chem
PubMed ID:11956213
A problem for inositol signaling is to understand the significance of the kinases that convert inositol hexakisphosphate to diphosphoinositol polyphosphates. This kinase activity is catalyzed by Kcs1p in the yeast Saccharomyces cerevisiae. A kcs1Delta yeast strain that was transformed with a specifically  ... More
Angiogenic bFGF expression from gas-plasma treated scaffolds.
Authors:Bailey SR, Polan JL, Morse B, Wetherold S, Villanueva-Vedia RE, Waggoner D, Phelix C, Barera-Roderiquiz E, Goswami N, Munoz O, Agrawal CM,
Journal:Cardiovasc Radiat Med
PubMed ID:12974371
PURPOSE: In vivo experiments indicate that gas-plasma-treated D,L-polylactide polymers expressing basic fibroblast growth factor (bFGF) exhibit enhanced angiogenesis. bFGF is not a single entity, but it is instead a family of isoforms. Consequently, we sought to determine which bFGF isoforms and levels initiate angiogenesis in nude mice peritoneums. METHODS: Cytoplasmic ... More
Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.
Authors: Kirschner L S; Carney J A; Pack S D; Taymans S E; Giatzakis C; Cho Y S; Cho-Chung Y S; Stratakis C A;
Journal:Nat Genet
PubMed ID:10973256
Carney complex (CNC) is a multiple neoplasia syndrome characterized by spotty skin pigmentation, cardiac and other myxomas, endocrine tumours and psammomatous melanotic schwannomas. CNC is inherited as an autosomal dominant trait and the genes responsible have been mapped to 2p16 and 17q22-24 (refs 6, 7). Because of its similarities to ... More
Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression.
Authors: Liu Meng-Min; Albanese Chris; Anderson Carol M; Hilty Kristin; Webb Paul; Uht Rosalie M; Price Richard H Jr; Pestell Richard G; Kushner Peter J;
Journal:J Biol Chem
PubMed ID:11986316
Induction of cyclin D1 gene transcription by estrogen receptor alpha (ERalpha) plays an important role in estrogen-mediated proliferation. There is no classical estrogen response element in the cyclin D1 promoter, and induction by ERalpha has been mapped to an alternative response element, a cyclic AMP-response element at -57, with possible ... More